Stimuli that induce a cholinergic neuronal phenotype of NG108-15 cells upregulate ChAT and VAChT mRNAs but fail to increase VAChT protein
Language English Country United States Media print
Document type Journal Article, Research Support, Non-U.S. Gov't
PubMed
11306187
DOI
10.1016/s0361-9230(00)00452-4
PII: S0361-9230(00)00452-4
Knihovny.cz E-resources
- MeSH
- Acetylcholine metabolism MeSH
- Anti-Inflammatory Agents pharmacology MeSH
- Cell Line MeSH
- Choline O-Acetyltransferase drug effects metabolism MeSH
- Choline metabolism MeSH
- Dexamethasone pharmacology MeSH
- Bucladesine pharmacology MeSH
- Phenotype MeSH
- Transcription, Genetic drug effects physiology MeSH
- Hybridomas cytology drug effects metabolism MeSH
- Keratolytic Agents pharmacology MeSH
- Membrane Transport Proteins * MeSH
- RNA, Messenger drug effects metabolism MeSH
- Nerve Tissue Proteins drug effects metabolism MeSH
- Carrier Proteins drug effects metabolism MeSH
- Tretinoin pharmacology MeSH
- Vesicular Acetylcholine Transport Proteins MeSH
- Vesicular Transport Proteins * MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Names of Substances
- Acetylcholine MeSH
- Anti-Inflammatory Agents MeSH
- Choline O-Acetyltransferase MeSH
- Choline MeSH
- Dexamethasone MeSH
- Bucladesine MeSH
- Keratolytic Agents MeSH
- Membrane Transport Proteins * MeSH
- RNA, Messenger MeSH
- Nerve Tissue Proteins MeSH
- Carrier Proteins MeSH
- Tretinoin MeSH
- Vesicular Acetylcholine Transport Proteins MeSH
- Vesicular Transport Proteins * MeSH
The vesicular acetylcholine transporter (VAChT) and choline acetyltransferase (ChAT) are encoded by genes organized in a single gene locus, and coregulation of the transcription of the two genes has been repeatedly reported in cholinergic tissues. In the present study, different stimuli were used to induce the differentiation of the hybridoma cells NG108-15 and we examined their effects on the modulation of VAChT and ChAT expression at the mRNA and protein levels. All agents upregulated the VAChT and ChAT mRNA levels, but to a different extent. ChAT activity was increased by retinoic acid, dexamethasone, and dibutyrylcyclic AMP (dbcAMP), and a synergistic effect was observed with a combined dexamethasone and dbcAMP treatment. Nonetheless, no changes in the VAChT protein level could be observed, as judged from ligand binding studies as well as from immunochemical detection. Hemicholinium-3-sensitive choline uptake, hemicholinium-3 binding, and acetylcholine content were increased by differentiating agents, with a rank order of potency comparable to their effects on ChAT activity. Prominent changes were observed in the expression of vesicular protein markers, particularly with the associated treatment dexamethasone and dbcAMP. Thus, it appears that although the different stimuli we have been using are able to stimulate neuronal features and activate the transcription of cholinergic genes, they did not contrive to increase the level of VAChT protein in these cells.
References provided by Crossref.org
Beta-amyloid and cholinergic neurons